Allianz Asset Management Gmb H Enanta Pharmaceuticals Inc Transaction History

Allianz Asset Management Gmb H

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$38.13 - $76.93 $826,086 - $1.67 Million	-21,665 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$60.19 - $97.37 $1.3 Million - $2.11 Million	21,665 New	21,665 $1.62 Million
Q1 2019 May 13, 2019	SELL	$69.08 - $105.66 $912,892 - $1.4 Million	-13,215 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$65.41 - $84.65 $30,284 - $39,192	463 Added 3.63%	13,215 $936,000
Q3 2018 Nov 13, 2018	BUY	$85.46 - $126.37 $871,179 - $1.29 Million	10,194 Added 398.51%	12,752 $1.09 Million

Q2 2018 Aug 13, 2018	BUY	$81.85 - $120.51 $209,372 - $308,264	2,558 New	2,558 $296,000

108

21.7M

9.4K

3.3K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $269M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.